REG - Hays PLC - CEO Medical Leave

HaysAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251110:nRSJ7566Ga&default-theme=true

RNS Number : 7566G  Hays PLC  10 November 2025

 

10 November 2025

Hays plc ("Hays")

CEO Medical Leave

 

Dirk Hahn, Chief Executive Officer at Hays, is currently taking medical leave,
having recently undergone surgery. Dirk's recovery is progressing positively
and he is expected to return to the business early in the new year.

 

Michael Findlay, Group Chair, will become Executive Chair until Dirk returns,
after which he will revert to being Non-Executive Chair. Michael will work
closely with the wider Hays management team to continue to drive forward the
Group's strategic and commercial priorities.

 

Everyone at Hays wishes Dirk a quick recovery as he focuses on returning to
full health.

 

 

 

Enquiries

 Hays plc                                              General Counsel & Company Secretary

 Rachel Ford                                           Head of Investor Relations & ESG         +44 (0) 333 010 2682

Kean Marden

                                                                                              +44 (0) 333 010 7092
 FGS Global

Guy Lamming / Anjali Unnikrishnan / Richard Crowley

hays@fgsglobal.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STRDDLFBEFLLFBL



            Copyright 2019 Regulatory News Service, all rights reserved